Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-23

FDA Approved: BRIVARACETAM — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a generic injectable form of brivaracetam under an ANDA for PAI Holdings (PAI Pharma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM INJECTION)